April 1, 2011
Posted by admin
Reuters interviews ACT’s Dr. Robert Lanza: Embryonic stem cells still “gold standard”
Following are excerpts from a Reuters story that ran on March 31, 2011; it includes quotes from an interview with ACT’s Chief Scientific Officer, Dr. Robert Lanza.
The original article may be found here.
ANALYSIS-Imperfections mar hopes for reprogrammed stem cells
31 Mar 2011 19:12
Source: Reuters // Reuters
* Reprogrammed stem cells rife with mutations, problems
* Embryonic [...]